Annals of Surgical Oncology

, Volume 16, Issue 7, pp 1745–1750 | Cite as

Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al.

  • Reid B. Adams
  • Peter J. Allen
Consensus Report: Resectable and Borderline Resectable Pancreas Cancer


Pancreatic Cancer Superior Mesenteric Artery Pancreatic Adenocarcinoma Margin Status Vascular Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Fortner JG. Regional resection and pancreatic carcinoma. Surgery. 1973;73:799–800.PubMedGoogle Scholar
  2. 2.
    Pawlik TM, Abdalla EK, Barnett CC, et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg. 2005;140:584–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Greene F, Page D, Fleming I, et al. AJCC cancer staging manual. New York: Springer, 2002.CrossRefGoogle Scholar
  4. 4.
    Tomlinson JS, Jain S, Bentrem DJ, et al. Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg. 2007;142:767–23.Google Scholar
  5. 5.
    Wong SL, Ji H, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Simunovic M, Baxter NN. Lymph node counts in colon cancer surgery: lessons for users of quality indicators. JAMA. 2007;298:2194–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004;8:935–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Riediger H, Makowiec F, Fischer E, et al. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg. 2006;10:1106–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007;245:777–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Chappel AR, Zuckerman RS, Finlayson SR. Small rural hospitals and high-risk operations: how would regionalization affect surgical volume and hospital revenue? J Am Coll Surg. 2006;203:599–604.PubMedCrossRefGoogle Scholar
  11. 11.
    Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137:511–20.PubMedGoogle Scholar
  12. 12.
    Loyer EM, David CL, Dubrow RA, et al. Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging. 1996;21:202–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Lu DS, Reber HA, Krasny RM, et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol. 1997;168:1439–43.PubMedGoogle Scholar
  14. 14.
    O’Malley ME, Boland GW, Wood BJ, et al. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol. 1999;173:1513–8.PubMedGoogle Scholar
  15. 15.
    Phoa SS, Reeders JW, Stoker J, et al. CT criteria for venous invasion in patients with pancreatic head carcinoma. Br J Radiol. 2000;73(875):1159–64.PubMedGoogle Scholar
  16. 16.
    Diehl SJ, Lehmann KJ, Sadick M, et al. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology. 1998;206:373–8.PubMedGoogle Scholar
  17. 17.
    Bilimoria KY, Bentrem DJ, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume. Cancer. 2007;110:1227–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567–79.PubMedCrossRefGoogle Scholar
  19. 19.
    Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–94.PubMedCrossRefGoogle Scholar
  20. 20.
    Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52–60.PubMedCrossRefGoogle Scholar
  21. 21.
    Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Butturini G, Stocken DD, Wente MN, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg. 2008;143:75–83.PubMedCrossRefGoogle Scholar
  23. 23.
    Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–46.PubMedCrossRefGoogle Scholar
  24. 24.
    Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2008;206:833–46.PubMedCrossRefGoogle Scholar
  25. 25.
    Pingpank JF, Hoffman JP, Ross EA, et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg. 2001;5:121–30.PubMedCrossRefGoogle Scholar
  26. 26.
    Howard TJ, Krug JE, Yu J, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 2006;10:1338–45.PubMedCrossRefGoogle Scholar
  27. 27.
    Tseng JF, Pisters PW, Lee JE, et al. The learning curve in pancreatic surgery. Surgery. 2007;141:694–701.PubMedCrossRefGoogle Scholar
  28. 28.
    Miner TJ, Jaques DP, Karpeh MS, Brennan MF. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg. 2004;198:1013–21.PubMedCrossRefGoogle Scholar
  29. 29.
    McCahill LE, Krouse RS, Chu DZ, et al. Decision making in palliative surgery. J Am Coll Surg. 2002;195:411–22.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  1. 1.Department of Surgery, Hepatobiliary and Pancreatic SurgeryUniversity of Virginia Health SystemCharlottesville USA
  2. 2.Hepatopancreatobiliary ServiceMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations